PG&E’s net income climbs despite wildfire liability questions
Despite questions raised about the company’s liability for the fires in Northern California and a slight drop in operating revenues, net income for Pacific Gas and Electric Co. rose 41 percent for the quarter ended Sept. 30. In an earnings release Nov. 2, the company brought down its full-year earnings guidance, citing the reinstatement of Read More →
Read More →Net income rises at Community West Bank
Community West Bancshares, parent company of Goleta-based Community West Bank, reported a net income of $1.6 million, or 18 cents per diluted share, for the quarter ended Sept 30 — an increase of 4.9 percent from $1.5 million in the third quarter of 2016. The bank’s net interest margin for Q3 2017 was 4.27 percent. Read More →
Read More →Increased sales at Teledyne boost net income
Sales for Thousand Oaks-based Teledyne rose more than 25 percent for the third quarter of 2017, boosting net income up 32.7 percent to $69 million, or $1.90 per diluted share. Aerospace and defense electronics sales rose 7.6 percent for the company, and engineered systems sales increased nearly 10 percent to $73.1 million. Sales in the Read More →
Read More →Available retail space on State Street growing
There are twice as many available retail spaces on State Street than there were in 2015 and available retail square footage has almost tripled since 2016, according to speakers at the 10th annual Radius Real Estate and Economic Forecast at the Fess Parker — A Doubletree by Hilton Resort on Nov 1. The event featured Read More →
Read More →Frontier revenue dips but net losses smaller
Frontier Communications saw a slight dip in third quarter revenue but smaller net losses year-over year, the company announced Oct. 31. Revenue reached $2.25 billion, down slightly from the previous quarter and the third quarter of 2016. But the first nine months of the year saw a 6.5 percent increase in revenue over the same Read More →
Read More →Amgen buying out joint venture Kirin-Amgen for $780 million
Amgen, the biotech giant based in Thousand Oaks, announced that it would buy out joint venture Kirin-Amgen, which was created to develop white blood cell booster Neupogen among other projects, for $780 million. The joint venture holds intellectual property rights for Neupogen, Neulasta, Aranesp, Nplate and brodalumab. In addition to the cash deal, Amgen will Read More →
Read More →